Atlas Trials

Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants

Clinical trial NCT06830954 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06830954
Sponsor
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2025-02-01
Primary completion
2025-05-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.